Key terms
About WAT
Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest WAT news
Apr 05
12:20am ET
Analysts Offer Insights on Healthcare Companies: Waters (WAT) and UnitedHealth (UNH)
Mar 15
9:39am ET
China stimulus positive for GE HealthCare, tool companies, says Evercore ISI
Feb 12
8:32am ET
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Waters (WAT) and Biohaven Ltd. (BHVN)
Feb 12
5:55am ET
Waters price target raised to $300 from $275 at Barclays
Feb 11
8:20pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Baxter International (BAX) and Waters (WAT)
Feb 07
8:30am ET
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Waters (WAT) and Bristol-Myers Squibb (BMY)
Feb 07
8:26am ET
Waters Corporation: Cautious Hold Amidst China Headwinds and Mixed Outlook
Feb 07
7:26am ET
Waters price target raised to $350 from $333 at TD Cowen
Feb 07
6:56am ET
Waters price target raised to $315 from $289 at Baird
Feb 06
9:40pm ET
Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC) and Waters (WAT)
Feb 06
9:30pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Qiagen (QGEN) and Waters (WAT)
Feb 06
7:00am ET
Waters sees FY24 EPS $11.75-$12.05, consensus $11.97
Feb 06
6:59am ET
Waters sees Q1 EPS $2.05-$2.15, consensus $2.39
Feb 06
6:56am ET
Waters reports Q4 EPS $3.62, consensus $3.55
Jan 24
7:20am ET
Waters price target raised to $275 from $230 at Barclays
No recent press releases are available for WAT
WAT Financials
Key terms
Ad Feedback
WAT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
WAT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range